שולי רווח נקי ImmuCell Corp. (ICCC)

Global logistics disruptions and currency fluctuations are weighing on the profitability of ImmuCell Corporation, as evidenced by the basic net sales margin, where this figure stands at 5.70. The implementation of innovative First Defense calf protection tools strengthens the brand's position, while the expansion of production capacities allows for the optimization of laboratory costs, creating powerful operating leverage for profit growth.
ImmuCell Corp. (ICCC) - פילוחי מדדים ודוחות פיננסיים

Strict control over biochemical waste disposal at ImmuCell Corporation (ICCC) directly impacts operating expenses. Net profit margin compares final profit to revenue, measuring the efficiency of overall expense management. The sales margin trajectory on GURU.Markets clearly demonstrates the business's ability to convert revenue into real capital. This metric reveals hidden issues within the cost structure. A stable indicator confirms the fundamental resilience of the asset's market value.